EATG » News

Webinar: Introduction to medicine research and development

EATG will host a webinar, Introduction to medicine research and development, on Thursday, 26 April 2018, 18:00 – 19:00 CEST (Brussels, Berlin, Paris time). The webinar will be led by…

Positive Stories: the voices of women living with HIV across Europe

The EATG has launched a new initiative aiming to give women living with or affected by HIV a platform to make their voices heard. Positive Stories is an empowerment tool…

Grindr sharing the HIV status and other personal information of their users with third parties without their informed consent is unacceptable

The EATG is disturbed by the news, reported by BuzzFeed News, about Grindr sharing the HIV status information of their users with two third companies, Apptimize and Localytics. Such actions…

PARADIGM: A collaborative initiative on patient engagement kicks-off

PARADIGM (Patients Active in Research and Dialogues for an Improved Generation of Medicines), a new initiative regarding patient engagement in research and development of medicines, was launched this week during…

STEP-UP 2018/19: Call for participants

The European AIDS Treatment Group (EATG) is happy to launch the call for participants for the STEP-UP 2018/19 training programme today. The STEP-UP programme is designed for people living with…

Metrodora: Webinar on women’s participation in HIV research

EATG will host a webinar on women’s participation in HIV research on 4 April 2018, 17:00 – 18:00 CET (Brussels, Berlin, Paris time). The webinar is organized within the context…

Civil society and patient organisations are seeking EU leadership and action on HIV, Hepatitis and TB

The European AIDS Treatment Group, along with other civil society and patients organisations, has co-signed an open letter to Commissioner Andriukaitis in view of the upcoming Staff Working Document on…

Organisations are urging Commissioner Andriukaitis to foster EU Member States’ response to Tuberculosis

In view of upcoming World Tuberculosis (TB) Day on March 24, the TB Europe Coalition, supported by 34 civil society and community organisations, urge Commissioner Andriukaitis to make a public…

Call for WHO & UNODC to revise guidelines on International Standards for the Treatment of Drug Use Disorders

The European AIDS Treatment Group together with 188 organisations has co-signed an open letter initiative by the International Network of People who use Drugs addressed to the WHO and UNODC…

HIVACAR: EATG reports from the second general assembly of the consortium

On March 15-16 the European AIDS Treatment Group participated in the second general assembly meeting of the HIVACAR consortium in Digem (Belgium). The EATG in collaboration with the Complutense University…

Webinar: Patient-reported Outcomes (PROs)

We invite you to join the webinar on What are patient-reported outcome measures and how are they used in drug development? taking place on Tuesday, 27 March 2018, 18:00 –…

THE EU CIVIL SOCIETY FORUM ON HIV, TB AND VIRAL HEPATITIS URGES THE EUROPEAN COMMISSION TO PRIORITIZE PUBLIC HEALTH WITHIN THE UPCOMING FINANCIAL FRAMEWORK

On 6 March the EU Civil Society Forum on HIV, TB and Viral Hepatitis wrote to the European Commission President Juncker, as well as Budget and Health Commissioners, in response to the…

Metrodora: Call for applications in the Multi-Stakeholders’ Meeting

Call for applications: Multi-Stakeholders’ Meeting Meaningful Engagement of Women in HIV Treatment Research Wednesday 16 May 2018, Park Inn Hotel, Brussels, Belgium   The Meeting: Within the framework of the…

The EU Civil Society Forum on HIV, TB and Viral Hepatitis calls the Romanian Ministry of Health to take on a leadership role on EU viral hepatitis policies

On 26 February, the EU Civil Society Forum on HIV, TB and Viral Hepatitis wrote to the Romanian Ministry of Health to request that it uses its convening power and…

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention,…

Community reception at CROI 2018

You are invited to the annual Community reception at CROI on 6 March 2018! For full details, please download the invitation for the event here: Community reception at CROI 2018,…

Presentations from the PrEP Summit now online

Organised jointly by EATG, AVAC, AIDSfonds, AIDES, AIDS Action Europe, NAM-AIDSMAP, NAT, Prepster, UNAIDS, WHO, the European PrEP Summit was organised in Amsterdam on 9-10 February 2018. The more than…

Advancing Community Agency – EATG Stakeholder Meeting in Brussels

The European AIDS Treatment Group held its annual Stakeholder Meeting in Brussels on 22 January 2018. The event welcomed 21 guests - partners and funders of EATG - who met…

M-Care 2018: Call for participants

The European AIDS Treatment Group (EATG) and the Africa Advocacy Foundation (AAF) are announcing a call for participants for the M-Care 2018 training programme. The goal of the training is…

DATE CHANGE for the 3rd Ageing with HIV Conference

The 3rd Ageing with HIV conference that was scheduled to be held on the 22-25 March 2018 has been postponed to 3-6 May 2018. The venue (Kyiv, Ukraine) and the overall timing (opening…

The collapse of the Venezuelan health system

When Hugo Chavez became Venezuela's new president in 1998, he promised to provide free health care to all and enshrined this right within Venezuela's new constitution, rewritten in 1999. Progress…

Claims of sexual harassment and assault threaten UN agency

Sexual harassment and assault investigation at UNAIDS draws attention to an endemic problem. Critics say the UN's internal system is flawed and call for external oversight. John Zarocostas reports in…

Orban not delivering health for Hungary

Viktor Orban's re-election to a third consecutive term in Hungary offers a preview for western countries of what the health consequences could be for governments that value populism and economic…

Russian government drafts bill to fight AIDS denial

The Russian government has drafted legislation that would make it illegal to urge people not to seek treatment for AIDS or to deny the existence of HIV, the virus that…

Many European countries are not ready to stop viral hepatitis

Patient groups from 25 European countries participated in the Hep-CORE study Many European countries lack a comprehensive policy to eliminate viral hepatitis as a major public health threat, according to…

WHO response to STREAM Stage 1 preliminary results

WHO issues a position statement on the continued use of the shorter MDR-TB regimen following an expedited review of the STREAM Stage 1 preliminary result. 13 April, Geneva - In…

Source:
WHO
Read more...

The upcoming UN general assembly resolution on TB must also benefit children

The United Nations High-Level Meeting on TB in September 2018 marks an unprecedented opportunity to strengthen countries' commitment to ending TB, but new resolutions should also benefit children. In a…

Chasing a new way to prevent HIV: passive immunization

After decades of intense effort, an effective vaccine against HIV is not on the horizon — and, some say, may never be possible. So some AIDS researchers are going passive.…

Source:
NPR
Read more...

HIV-1 viruses transmitted at birth are resistant to antibodies in mother’s blood

New research supports creation of vaccine to boost mother's immune response to HIV-1 before delivery Of the genetically diverse population of HIV-1 viruses present in an infected pregnant woman, the…

Study: Anxiety, depression can lengthen delay between HIV “test and treat”

Living with severe depression or an anxiety disorder can have a similar impact on patients’ promptness in seeking care following an HIV diagnosis as living far from a clinic, according…

Study finds increased survival and cure rates for patients with HIV and MDR-TB when infections treated concurrently

Patients co-infected with HIV and multidrug-resistant tuberculosis (MDR-TB) can achieve similar survival and tuberculosis cure rates to those infected with MDR-TB but not HIV when treated concurrently for both infections,…

First long-term study finds half trillion dollars spent on HIV/AIDS

Top HIV cure research team refutes major recent results on how to identify HIV persistence

Collaborative effort sets the record straight on the use of CD32 as a biomarker to measure HIV reservoirs. PHILADELPHIA — (April 18, 2018) — An international team focused on HIV…

Paul Sax: Latest DHHS guidelines for initial HIV therapy now include 5 choices, but really 2 are best

On March 28, the Department of Health and Human Services Guidelines issued an update to the HIV treatment guidelines, with a focus on the recent approval of bictegravir/TAF/FTC: BIC/TAF/FTC is…

HIV-associated cancers: a paradigm shift?

An increasing number of patients with HIV now live long enough to get the “incidental” cancers seen in the general population. Yet these patients are also less likely to get…

HPV vaccine lacks efficacy in adults with HIV

Results of a phase 3 trial recently published in Clinical Infectious Diseases showed that the quadrivalent HPV vaccine was not effective in preventing new anal infections or improving high-grade squamous…

Hepatitis C-infected heart and lung transplants safe

Hearts and lungs from people infected with hepatitis C are safe for transplantation because the virus can be effectively treated in the recipient, new data show. The cure for hepatitis C infection…

Novel digital ELISA may detect, quantify low HIV p24 concentrations in CSF

A novel digital enzyme-linked immunosorbent assay (ELISA) could be a tool used to further understand HIV central nervous system (CNS) involvement by having high sensitivity for the HIV p24 antigen…

HIV criminalisation deters men from testing and can increase HIV transmission rates

Findings show that fear of prosecution can drive new infections, as it puts men off knowing their status. A new study published in medical journal PLOS ONE highlights how laws…

Generic HIV medicines: boon or bust?

The advent of generic HIV medications in the 2000s had a dramatic effect on improving outcomes in developing countries with a high HIV/AIDS burden. Before that, death rates were skyrocketing…